The treatment effect was evaluated in Imaris reconstructions (Fig. 4A, upper row) from immunofluorescences (Fig. 4A, lower row) via quantification of the GFP signal expressed in S24 GBM cells (Fig. 4B, upper graph), and by quantification of the fraction of Ki67-positive cells (Fig. 4B, lower graph). This evidence concerns the gene MKI67 and glioblastoma.